References
- Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, . Practice Parameter update. The care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioural impairment (an evidence-based review). Neurology. 2009; 73:1227–33.
- Hadjikoutis S, Wiles CM. Respiratory complications related to bulbar dysfunction in motor neuron disease. Acta Neurologica Scandinavica. 2001;103:207–13.
- Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. The Lancet Neurology. 2006;5:140–7.
- Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, . Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler. 2007;8:195–213.
- Mirakhur RK, Dundee JW. Comparison of the effects of atropine and glycopyrrolate on various end-organs. J R Soc Med. 1980;73:727–30.
- Arbouw MEL, Movig KLL, Koopmann M, Poels PJE, Guchelaar H-J, Egberts TCG, . Glycopyrrolate for sialorrhoea in Parkinson's disease. Neurology. 2010; 74:1203–7.
- Fuder H, Meincke M. Glycopyrronium bromide blocks differentially responses mediated by muscarinic receptor subtypes. Naunyn Schmiedebergs Arch Pharmacol. 1993;347:591–5.
- Strutt R, Fardell B, Chye R. Nebulized glycopyrrolate for drooling in a motor neuron patient. Journal of Pain and Symptom Management. 2002;23:2–3.
- Jackson CE, Gronseth G, Rosenfeld J, Barohn RJ, Dubinsky R, Simpson CB, . Randomized double-blind study of botulinum toxin type B for sialorrhoea in ALS patients. Muscle & Nerve. 2009;39:137–43.
- Dogu O, Apaydin D, Sevim S, Talas DU, Aral M. Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clinical Neurology and Neurosurgery. 2004;106:93–6.